April 2024, Vol 30, No. 2

Pharmaceutical Sciences is a peer-reviewed, and quarterly journal providing a forum for basic to clinical issues related to all areas of pharmaceutical sciences. It is the official journal of Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.
- Platinum Open Access (no processing or publication fees)
- Indexed in Web of Science Core Collection (Impact Factor 2022: 1.7) and Scopus
- Average time to first decision in 2023 (all decisions): 17 days
- Time to first post-review decision in 2023: 2-8 weeks
- Acceptance rate in 2023: 10%
- Publications from 18 countries (5 continents) in 2023

Research Article

1. MCF-7 and its Multidrug Resistant Variant MCF-7/ADR Overcome TNF Cytotoxicity through Prevention of Reactive Oxygen Species Accumulation

Morteza Ghandadi , Javad Behravan, Samira Biabani, Sara Abbaspor, Fatemeh Mosaffa*

Pharm Sci. 2019;25(2): 118-123. doi: 10.15171/PS.2019.18

Scopus ID: 85069209477

Article

PDF

XML

Cited By:

Research Article

2. Synthesis, Molecular Docking and Anticancer Activity of Novel 1,3-Thiazolidin-4-Ones

Ramesh Sawant* , Jyoti Wadekar , Rushikesh Ukirde, Ganesh Barkade

Pharm Sci. 2021;27(3): 345-352. doi: 10.34172/PS.2020.95

Scopus ID: 85115211727

Article

PDF

XML

Cited By:

Research Article

3. **Concanavalin-A Shows Synergistic Cytotoxicity with Tamoxifen via Inducing Apoptosis in Estrogen Receptor-Positive Breast Cancer: In Vitro and Molecular Docking Studies**

Mohamed Elshal , Norhan Eid, Ibrahim El-Sayed, Wael El-Sayed, Ahmed Ali Al-Karmalawy*

Pharm Sci. 2022;28(1): 76-85. doi: 10.34172/PS.2021.22

Scopus ID: 85127089761

Article

PDF

XML

Cited By:

Research Article

4. Anti-proliferative and Apoptotic Effect of Tetrahydrobenzo[h]quinoline on MCF-7 Human Breast Cancer Cell

Maryam Ghaffari, Dariush Shanehbandi, Solmaz Sarhadi, Mina Hanifeh Ahagh, Mahsa Maleki Moghaddam, Gholamreza Dehghan, Razieh Ghodsi, Jafar Ezzati Nazhad Dolatabadi*

Pharm Sci. 2022;28(2): 304-313. doi: 10.34172/PS.2021.58

Scopus ID: 85132948918

Article

PDF

XML

Cited By:

Submit Your Paper Editorial Board Instructions for Authors Instructions for Reviewers Contact Us Editorial Policies Peer Review Archive

Indexing & Abstracting:

Follow us on LinkedIn
Follow us on Twitter

Director-in-Charge:
Prof. Khosro Adibkia

Editor-in-Chief:
Prof. Ali Shayanfar

Follower of ICMJE

1. MCF-7 and its Multidrug Resistant Variant MCF-7/ADR Overcome TNF Cytotoxicity through Prevention of Reactive Oxygen Species Accumulation

2. Synthesis, Molecular Docking and Anticancer Activity of Novel 1,3-Thiazolidin-4-Ones

3. Concanavalin-A Shows Synergistic Cytotoxicity with Tamoxifen via Inducing Apoptosis in Estrogen Receptor-Positive Breast Cancer: In Vitro and Molecular Docking Studies

4. Anti-proliferative and Apoptotic Effect of Tetrahydrobenzo[h]quinoline on MCF-7 Human Breast Cancer Cell

3. **Concanavalin-A Shows Synergistic Cytotoxicity with Tamoxifen via Inducing Apoptosis in Estrogen Receptor-Positive Breast Cancer: In Vitro and Molecular Docking Studies**